CRISPR-Cpf1 Antibody (2D5-6G11) Summary
Partial recombinant protein made to an N-terminal portion of the Lachnospiraceae bacterium CRISPR-Cpf1 protein
This antibody is specific for Lachnospiraceae bacterium CRISPR-Cpf1.
Protein A or G purified
Test in a species/application not listed above to receive a full credit towards a future purchase.
Packaging, Storage & Formulations
Store at 4C short term. Aliquot and store at -20C long term. Avoid freeze-thaw cycles.
0.02% Sodium Azide
Protein A or G purified
Alternate Names for CRISPR-Cpf1 Antibody (2D5-6G11)
- anti-cas12a antibody
- Clustered regularly interspaced short palindromic repeat (CRISPR) associated Cas12a
- CRISPR-associated endonuclease Cas12a
- CRISPR-associated endonuclease Cpf1
Clustered Regularly Interspaced Short Palindromic Repeat (CRISPR) is an adaptive immune system in bacteria which provides protection against mobile genetic elements from viruses such as, transposable elements and conjugative plasmids. CRISPR clusters are known to have sequences which are complementary to antecedent mobile elements and target invading nucleic acids, and these sequences are transcribed/processed into CRISPR RNA. CRISPR possess endonuclease activity on pre-crRNA and dsDNA, using different active sites, and in a complexed form, crRNA displaces the non-target DNA strand and guides endo-nucleolytic cleavage of both strands of the DNA. CRISPR associated Cas12a (CRISPR-Cas12a), also known as Cpf1, is emerging as a genome editing tool with different target specificity, when compared to CRISPR-Cas9. CRISPR-Cas12a-assisted recombineering can be used for genetic manipulation of plasmids, plasmid curing and for a more precise selection of target sites for the introduction of desired mutations (point mutations, deletions, insertions, and replacements). In cells subjected to genetic manipulation using this tool, CRISPR-Cas12a antibodies are needed to verify transfection efficiency, CRISPR-Cas12a expression, CRISPR-Cas12a target binding and subcellular localization. Novus Biologicals' CRISPR-Cpf1 antibody (NBP2-62735) is the first-ever commercially launched antibody to meet this need. This antibody is generated against a partial recombinant Francisella tularensis protein (between amino acids 600-850) [NCBI WP_003034647.1], and validated for Western blot using a partial recombinant CRISPR-Cpf1 protein (12kDa), making it a great tool for a direct detection of CRISPR-Cpf1/CRISPR-Cas12a complex (at protein level) superior to the use of epitope-tag based validation approaches.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed
for 1 year from date of receipt.
Publications for CRISPR-Cpf1 Antibody (NBP2-78819) (0)
There are no publications for CRISPR-Cpf1 Antibody (NBP2-78819).
By submitting your publication information earn gift cards and discounts for future purchases.
Reviews for CRISPR-Cpf1 Antibody (NBP2-78819) (0)
There are no reviews for CRISPR-Cpf1 Antibody (NBP2-78819).
By submitting a review you will receive an Amazon e-Gift Card or Novus Product Discount.
- Review with no image -- $10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen
- Review with an image -- $25/€18/£15/$25 CAD/¥150 Yuan/¥2500 Yen
Product General Protocols
Find general support by application which include: protocols, troubleshooting, illustrated assays, videos and webinars.
FAQs for CRISPR-Cpf1 Antibody (NBP2-78819) (0)
Other Available Formats
Additional CRISPR-Cpf1 Products
Blogs on CRISPR-Cpf1